title: Clinical significance of basal-like breast cancer in Chinese women in Heilongjiang province.
abstract: BACKGROUND
  Our objective was to clarify the clinical and biological characteristics of basal-like breast cancer (BLBC) and non-basal-like breast cancer (TN3BKE) in Heilongjiang.
  
  
  METHODS
  We examined, by immunohistochemistry, expression of biological markers cytokeratin (CK) 5/6 and epidermal growth factor receptor (EGFR) and B cell specific moloney murine leukemia virus integration site 1( Bmi-1) in triple-negative breast cancer (TNBC). We studied the correlation between BLBC and several factors related to tumor progression, along with its prognostic value.
  
  
  RESULTS
  In the 229 cases of operable TNBC, BLBC was detected in 178 (77.7%) and TN3BKE- in 51 (22.2%). There was no significant difference in clinicopathological factors between them, However, BLBC was significantly associated with Bmi-1 expression (P=0.000) and shorter disease-free survival (DFS) (P = 0.045) and overall survival (OS) (P=0.041).
  
  
  CONCLUSIONS
  Compared with the non-basal group, patients with BLBC have a high expression of Bmi-1 and a poor prognosis.
authors.affiliation: Department of Oncology, Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China. ingliu1983@126.com
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Qiu-Ying
authors.initials: QY
authors.lastname: Jiang
authors.forename: Tao
authors.initials: T
authors.lastname: Xin
authors.forename: Li
authors.initials: L
authors.lastname: Cai
authors.forename: Chang-Hong
authors.initials: CH
authors.lastname: Zhao
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D002681:China; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D053555:Keratin-5 / Q000378:metabolism*; D053553:Keratin-6 / Q000378:metabolism*; D063150:Polycomb Repressive Complex 1 / Q000096:biosynthesis*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D053555:Keratin-5; D053553:Keratin-6; D063150:Polycomb Repressive Complex 1; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C069077:BMI1 protein, human